Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The target name "Hepatocyte growth factor-activated kinase" is incorrectly specified or imprecise. There is no protein or enzyme with this exact canonical name. The search results consistently describe Hepatocyte Growth Factor (HGF) and its receptor c-Met (hepatocyte growth factor receptor), but not a kinase specifically named "hepatocyte growth factor-activated kinase." What does exist: HGF (a cytokine ligand), c-Met (a receptor tyrosine kinase activated by HGF), Akt kinase (a downstream kinase activated by HGF signaling), and Hepatocyte Growth Factor Activator (HGFAC, a serine protease). The query may be referring to c-Met receptor tyrosine kinase, Akt kinase, or MAPK (mitogen-activated protein kinase), which are all involved in HGF signaling pathways.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Hepatocyte Growth Factor-Activated Kinase.